CHRNA3 can potentially be used as a biomarker for early detection of lung cancer. Blood tests or other diagnostic methods that detect changes in the expression levels or mutations of CHRNA3 might help in identifying individuals at risk. Early diagnosis is crucial for improving the prognosis and survival rates of cancer patients.
